| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.1B | $-0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $-7.65 | $-1.46 | $3.51 | $5.53 | $3.50 | $0.45 | $0.56 | $1.30 |
| EPS (Diluted) | $-7.65 | $-1.46 | $3.49 | $5.46 | $3.47 | $0.45 | $0.56 | $1.29 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.1B | $9.4B | $9.4B | $7.2B | $7.2B | $6.8B | $7.0B | $6.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $7.7B | $8.9B | $8.8B | $6.5B | $6.5B | $6.1B | $6.3B | $6.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.4B | $0.5B | $0.6B | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $0.0B | $0.2B | $0.2B | $-0.0B | $0.3B | $0.3B | $0.2B |
| Investing Cash Flow | $1.3B | $0.5B | $-2.7B | $-0.1B | $-0.2B | $0.1B | $-0.6B | $-0.6B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.1B | $-0.3B | $2.4B | $-0.0B | $0.3B | $-0.3B | $0.3B | $0.4B |